1 Vial — 10 g/100 ml (10%)
Privigen is a medication used to treat adults with chronic immune thrombocytopenia (ITP), an autoimmune disorder that causes low platelet levels and bleeding.
Privigen is an intravenous (IV) immunoglobulin (IG) product that is used to treat a variety of immune disorders, including primary immunodeficiencies, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and Kawasaki disease. This product contains a high concentration of purified, pasteurized, and concentrated IgG antibodies that are derived from large pools of human plasma. Privigen is designed to replenish the body’s depleted IgG reserves, helping to restore its immune system functionality. It is administered via IV infusion, wherein the antibodies are directly delivered into the bloodstream, providing a more rapid and effective response than oral medications. This product also features a low risk of allergic reactions due to its high purity and low levels of IgA. Furthermore, it is free of IgM, IgD, and IgE antibodies, allowing it to be safely used in patients with severe immunodeficiencies.
In addition, Privigen has a longer shelf life and requires no refrigerated storage, making it more convenient for patients and healthcare providers.